Kari Gillmeyer, MD, MSc

Assistant Professor, Medicine

Kari Gillmeyer
617.358.2800
72 E. Concord Street

Biography

Dr. Gillmeyer is a health services researcher with a career dedicated to improving quality of care and outcomes for vulnerable patients. Dr. Gillmeyer’s work focuses on pulmonary hypertension, a devastating, progressive disease that exerts a heavy burden on patients and health systems. Through her research, Dr. Gillmeyer hopes to improve the quality, safety, and equity of pulmonary hypertension care and to mitigate health disparities in pulmonary hypertension.

Other Positions

  • Member, Pulmonary Center, Boston University

Education

  • University of Minnesota Medical School, MD
  • South Dakota State University, BS

Publications

  • Published on 12/21/2023

    Morland K, Gerges C, Elwing J, Visovatti SH, Weatherald J, Gillmeyer KR, Sahay S, Mathai SC, Boucly A, Williams PG, Harikrishnan S, Minty EP, Hobohm L, Jose A, Badagliacca R, Lau EMT, Jing ZC, Vanderpool RR, Fauvel C, Leonidas Alves J, Strange G, Pulido T, Qian J, Li M, Mercurio V, Zelt JGE, Moles VM, Cirulis MM, Nikkho SM, Benza RL, Elliott CG. Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working Group. Pulm Circ. 2023 Oct; 13(4):e12317. PMID: 38144948.

    Read at: PubMed
  • Published on 11/13/2023

    Lui JK, Gillmeyer KR, Sangani RA, Smyth RJ, Gopal DM, Trojanowski MA, Bujor AM, Soylemez Wiener R, LaValley MP, Klings ES. A Clinical Decision Tool for Risk Stratifying Patients with Systemic Sclerosis-Related Pulmonary Hypertension. Lung. 2023 Dec; 201(6):565-569. PMID: 37957388.

    Read at: PubMed
  • Published on 6/1/2023

    Pang B, Kearney L, Maccarone J, Zhang J, Kearney C, Sangani R, Shankar DA, Gillmeyer KR, Law AC, Bosch NA. Association between Early Venous Thromboembolism Prophylaxis, Bleeding Risk, and Venous Thromboembolism among Critically Ill Patients with Thrombocytopenia. Ann Am Thorac Soc. 2023 Jun; 20(6):917-920. PMID: 36867519.

    Read at: PubMed
  • Published on 3/1/2023

    Li B, Gillmeyer KR, Molloy-Paolillo B, Vimalananda VG, Elwy AR, Wiener RS, Rinne ST. Scoping Review of Pulmonary Telemedicine Consults: Current Knowledge and Research Gaps. Ann Am Thorac Soc. 2023 Mar; 20(3):456-465. PMID: 36490386.

    Read at: PubMed
  • Published on 1/20/2023

    Lui JK, Sangani RA, Gillmeyer KR, Vakhshoorzadeh J, Trojanowski MA, Bujor AM, Gopal DM, Wiener RS, LaValley MP, Klings ES. Correction to: Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension. Cardiovasc Drugs Ther. 2023 Jan 20. PMID: 36662449.

    Read at: PubMed
  • Published on 1/18/2023

    Lui JK, Gillmeyer KR, Sangani RA, Smyth RJ, Gopal DM, Trojanowski MA, Bujor AM, Soylemez Wiener R, LaValley MP, Klings ES. A Multimodal Prediction Model for Diagnosing Pulmonary Hypertension in Systemic Sclerosis. Arthritis Care Res (Hoboken). 2023 Jul; 75(7):1462-1468. PMID: 35678779.

    Read at: PubMed
  • Published on 1/6/2023

    Lui JK, Sangani RA, Gillmeyer KR, Vakhshoorzadeh J, Trojanowski MA, Bujor AM, Gopal DM, Wiener RS, LaValley MP, Klings ES. Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension. Cardiovasc Drugs Ther. 2023 Jan 06. PMID: 36607535.

    Read at: PubMed
  • Published on 12/23/2022

    Gillmeyer KR, Johnson SW, Bolton RE, McCullough MB, Wiener RS. Organization of pulmonary hypertension care in non-expert care settings: Lessons learned from a multi-site study. Health Serv Res. 2023 Jun; 58(3):663-673. PMID: 36518045.

    Read at: PubMed
  • Published on 10/1/2022

    Sangani RA, Lui JK, Gillmeyer KR, Trojanowski MA, Bujor AM, LaValley MP, Klings ES. Clinical characteristics and outcomes in pulmonary manifestations of systemic sclerosis: Contribution from pulmonary hypertension and interstitial lung disease severity. Pulm Circ. 2022 Oct; 12(4):e12117. PMID: 36238967.

    Read at: PubMed
  • Published on 10/1/2022

    Gillmeyer KR, Rinne ST, Qian SX, Maron BA, Johnson SW, Klings ES, Wiener RS. Socioeconomically disadvantaged veterans experience treatment delays for pulmonary arterial hypertension. Pulm Circ. 2022 Oct; 12(4):e12171. PMID: 36568691.

    Read at: PubMed

View 12 more publications: View full profile at BUMC

View all profiles